Ameritas Investment Partners’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
VCM
PCM
GAM
LP
Ameritas Investment Partners's PLSE Position: Q1 2026 in Review
Ameritas Investment Partners reduced its Pulse Biosciences (PLSE) stake by 21% in Q1 2026, selling an estimated $7.29K and leaving 1,469 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.
Ameritas Investment Partners first reported a position in PLSE in Q2 2017 and has held it in 32 quarters since. The position peaked at $33K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Ameritas Investment Partners held 1,469 shares of Pulse Biosciences worth $31.7K as of Q1 2026.
- Ameritas Investment Partners sold 395 Pulse Biosciences shares in Q1 2026, an estimated $7.29K.
- Pulse Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2364 holding.
- Ameritas Investment Partners first reported a position in Pulse Biosciences in Q2 2017 and has held it in 32 quarters since.
- Ameritas Investment Partners's Pulse Biosciences position peaked at $33K in Q3 2025.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.